These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30833208)

  • 1. Mortality associated with cardiovascular drugs in patients with chronic obstructive pulmonary disease and right-sided heart failure - A danish nationwide registry-based study.
    Andersson C; Hansen PW; Steffensen IE; Andreasen C; Weeke PE; Køber L; Gislason GH; Torp-Pedersen C
    Eur J Intern Med; 2019 May; 63():56-61. PubMed ID: 30833208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
    Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
    Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark.
    Rasmussen DB; Bodtger U; Lamberts M; Nicolaisen SK; Sessa M; Capuano A; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Eur Heart J Qual Care Clin Outcomes; 2020 Jan; 6(1):23-31. PubMed ID: 30608575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis.
    Hippisley-Cox J; Coupland C
    BMJ; 2005 May; 330(7499):1059-63. PubMed ID: 15879390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA; Kulinskaya E; Steel N
    BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Blockers and All-Cause Mortality in Adults with Episodes of Acute Bronchitis: An Observational Study.
    Rutten FH; Groenwold RH; Sachs AP; Grobbee DE; Hoes AW
    PLoS One; 2013; 8(6):e67122. PubMed ID: 23840599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
    Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
    Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
    Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
    Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study.
    Frankenstein L; Katus HA; Grundtvig M; Hole T; de Blois J; Schellberg D; Atar D; Zugck C; Agewall S;
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1747-55. PubMed ID: 23743778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
    Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
    BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial.
    Rossi A; Inciardi RM; Rossi A; Temporelli PL; Lucci D; Gonzini L; Marchioli R; Nicolosi GL; Tavazzi L;
    Pulm Pharmacol Ther; 2017 Jun; 44():16-23. PubMed ID: 28263812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
    Fröhlich H; Rosenfeld N; Täger T; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L; Grundtvig M
    Heart; 2019 Aug; 105(16):1252-1259. PubMed ID: 30792238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between drug application and mortality rate in Chinese older coronary artery disease/chronic heart failure patients with and without low glomerular filtration rate.
    Fu S; Ping P; Ye P; Luo L
    BMC Pharmacol Toxicol; 2019 Jul; 20(1):44. PubMed ID: 31349878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving outcomes in chronic obstructive pulmonary disease by taking beta-blockers after acute myocardial infarction: a nationwide observational study.
    Wang WH; Cheng CC; Mar GY; Wei KC; Huang WC; Liu CP
    Heart Vessels; 2019 Jul; 34(7):1158-1167. PubMed ID: 30680495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study.
    Gayat E; Arrigo M; Littnerova S; Sato N; Parenica J; Ishihara S; Spinar J; Müller C; Harjola VP; Lassus J; Miró Ò; Maggioni AP; AlHabib KF; Choi DJ; Park JJ; Zhang Y; Zhang J; Januzzi JL; Kajimoto K; Cohen-Solal A; Mebazaa A;
    Eur J Heart Fail; 2018 Feb; 20(2):345-354. PubMed ID: 28849606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.